Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Brain gene therapy aims to tame Parkinson's tremors

NCT ID NCT07533591

First seen Apr 19, 2026 · Last updated May 19, 2026 · Updated 5 times

Summary

This early-stage trial tests a new gene therapy for Parkinson's disease. Six adults aged 40-70 with advanced Parkinson's will receive a brain injection of a specially designed virus (STP-001) that delivers a gene to calm overactive brain cells. After surgery, they will take a pill (clozapine) to activate the gene and improve movement symptoms. The main goal is to check safety over 3 months, not yet to prove it works.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE (PD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Second Affiliated Hospital, School of Medicine,Zhejiang University

    Zhejiang, Province, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.